Brand Asset Management Group’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-2,037
Closed -$132K 135
2021
Q1
$132K Buy
2,037
+8
+0.4% +$516 0.07% 88
2020
Q4
$118K Sell
2,029
-791
-28% -$47.7K 0.07% 82
2020
Q3
$178K Buy
2,820
+708
+34% +$49.1K 0.11% 71
2020
Q2
$162K Buy
2,112
+107
+5% +$8.2K 0.1% 69
2020
Q1
$150K Buy
2,005
+6
+0.3% +$415 0.11% 68
2019
Q4
$130K Buy
1,999
+7
+0.4% +$456 0.08% 83
2019
Q3
$126K Buy
1,992
+7
+0.4% +$458 0.08% 81
2019
Q2
$134K Buy
1,985
+6
+0.3% +$395 0.09% 76
2019
Q1
$129K Buy
1,979
+7
+0.4% +$465 0.09% 73
2018
Q4
$123K Buy
1,972
+6
+0.3% +$419 0.1% 69
2018
Q3
$152K Buy
1,966
+5
+0.3% +$378 0.11% 68
2018
Q2
$139K Buy
+1,961
New +$138K 0.11% 73

Other funds holding GILD

Brand Asset Management Group's GILD Position: Q2 2021 in Review

Brand Asset Management Group sold out of Gilead Sciences (GILD) in Q2 2021, closing a stake of 2,037 shares — an estimated $132K sold.

Brand Asset Management Group first reported a position in GILD in Q2 2018 and held it in 12 quarters. The position peaked at $178K in Q3 2020. 1,544 funds tracked by Wall St. Rank hold GILD as of Q2 2021.

  • Brand Asset Management Group reported no remaining Gilead Sciences position as of Q2 2021 after selling out during the quarter.
  • Brand Asset Management Group sold 2,037 Gilead Sciences shares in Q2 2021, an estimated $132K.
  • Brand Asset Management Group first reported a position in Gilead Sciences in Q2 2018 and held it in 12 quarters.
  • Brand Asset Management Group's Gilead Sciences position peaked at $178K in Q3 2020.
  • 1,544 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2021.

Based on Brand Asset Management Group's 13F filing for Q2 2021, filed 9 Aug 2021.